A dispensing association cannot establish the clinical reason for combining medicines.
A Japanese cross-sectional claims study found benzodiazepine anxiolytic polypharmacy in a minority of users and associations with other psychotropic prescribing patterns. It examined medication categories and demographic features over a defined period.
The study reported that 12.6% of adults prescribed benzodiazepine anxiolytics received anxiolytic polypharmacy during its one-month assessment. This denominator excludes people without such prescriptions. It also concerns anxiolytic classification rather than every possible sedative exposure. The absence of extracted diagnoses prevents testing whether specific combinations reflected separate conditions, a switch in treatment or another clinical explanation.
The dataset did not supply the diagnoses needed to evaluate each indication. Simultaneous records may also require clarification of intended switching, duration and actual use. Association with another drug class does not identify which prescribing decision came first.
Reconcile the individual prescriptions before treating a medication count as concurrent ingestion. The study can identify patterns for further review, but cannot by itself prove unnecessary treatment, dependence, intoxication or a specific clinician’s rationale.
Source: PMC11254787, supplied full-text paper. Findings are paraphrased; forensic implications are an interpretation.
Related: Seizure-Rescue Speed Includes the Time Needed to Deliver a Benzodiazepine.